P17.50 PHASE II STUDY OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS

BACKGROUND: Current standard treatment for GBM is surgery followed by radiation (RT) and temozolomide (TMZ). We published phase I data of the addition of arsenic trioxide (ATO) to RT and TMZ. We now present the phase II data. METHODS: Patients with newly diagnosed malignant gliomas were eligible for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kumthekar, P., Grimm, S.A., Marymont, M., Mehta, M., Chandler, J., Muro, K., Jovanovic, B., Helenowski, I., McCarthy, K., Raizer, J.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185748/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.379
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados